Key takeaways:
Mounjaro (tirzepatide) is a once-weekly injection that’s FDA approved to treat Type 2 diabetes. It has a number of interactions with other medications to be aware of.
Key Mounjaro drug interactions include insulin, sulfonylureas, and glinides. Combining Mounjaro with these other diabetes medications can raise your risk of low blood glucose (sugar).
Mounjaro may also affect how other oral medications are absorbed. Notably, birth control pills may be less effective for preventing pregnancy, especially when first starting Mounjaro and after dose increases.
Avoid combining Mounjaro with other medications that work similarly, such as Ozempic (semaglutide). Doing so can raise your risk of side effects, such as nausea and diarrhea.
Mounjaro (tirzepatide) is a convenient, once-a-week injectable medication for Type 2 diabetes. It works by signaling your pancreas to release insulin when you eat. It also slows down how fast your stomach empties and lowers the amount of glucose (sugar) made by your liver.
Mounjaro was the first medication FDA approved in a new class of medications called glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. But beyond this, Mounjaro has made headlines for its ability to promote significant weight loss. With all the buzz surrounding it, your endocrinologist (diabetes specialist) may have mentioned it as an option for you.
If you’re starting Mounjaro, drug interactions might not have been the first question to come to mind. But it’s good to know if it’s safe to combine with other medications you may take. Many interactions involve a drop in your blood glucose (hypoglycemia). But Mounjaro can also potentially interfere with oral medications, including birth control pills.
Save every month on GLP-1 meds with GoodRx
Save an average of $235 on FDA-approved GLP-1s like Ozempic and Zepbound.
Below, we’ll review five notable Mounjaro drug interactions you should know about. But you should share an updated medication list with your prescriber and pharmacist so they can double-check for Mounjaro interactions.
Some people with Type 2 diabetes use a combination of insulin and other diabetes medications, like Mounjaro, to help manage their blood glucose. However, combining both Mounjaro and insulin can raise the risk of hypoglycemia (blood glucose of less than 70 mg/dL). So extra caution is needed with this combination.
Watch for symptoms of hypoglycemia when administering both Mounjaro and insulin. These can include shakiness, sweating, and a fast heart rate. Hypoglycemia can be life-threatening in severe cases. So it’s important to treat it quickly if it happens to you.
To help prevent hypoglycemia, your endocrinologist may lower your dose of insulin when you first start Mounjaro. Be sure to check your blood glucose as instructed by your prescriber and let them know if you start experiencing low glucose levels.
Can you drink alcohol with Mounjaro? Learn why mixing alcohol and Mounjaro can raise the risk of digestive side effects.
What does Mounjaro feel like? Real people share their experiences with Mounjaro, which can be beneficial for many people living with Type 2 diabetes.
What side effects can you expect? Learn about Mounjaro’s side effects — from diarrhea to hair loss — and how to manage them.
Sulfonylureas are a commonly prescribed group of oral diabetes medications. Examples include glipizide (Glucotrol XL), glyburide (DiaBeta, Glynase), and glimepiride (Amaryl). Taking Mounjaro and sulfonylureas can also raise the risk of hypoglycemia.
Like Mounjaro, sulfonylureas signal your pancreas to release insulin. The difference is that sulfonylureas tell your pancreas to release insulin whether you’ve eaten or not. Taking a sulfonylurea and Mounjaro together may lead to the release of too much insulin. And this can cause hypoglycemia.
As with insulin, Mounjaro and sulfonylureas can still be taken together, if needed. Your endocrinologist may lower your sulfonylurea dose before you start Mounjaro. Be sure to let them know of any notable drops in glucose that happen after starting the combination, or after dose increases.
Meglitinides (“glinides”) are a less popular group of oral diabetes medications. Examples of glinides include repaglinide and nateglinide. Like sulfonylureas, they tell your pancreas to release insulin. But glinides work faster and their effects are shorter-lived than sulfonylureas.
Similar to the medications listed above, taking Mounjaro and a glinide together can raise the risk of hypoglycemia. If your endocrinologist prescribes both medications for you, they’ll likely adjust your glinide dose when first starting Mounjaro. Let your prescriber know if you start experiencing low glucose levels more frequently after starting both medications.
Mounjaro can make birth control pills less effective, especially when first starting Mounjaro or after dose increases. This can lead to unintended pregnancies or a return of symptoms you’re taking birth control to help manage.
This Mounjaro drug interaction happens because of how the medication works. Mounjaro slows down the movement of food from your stomach to the small intestine. Food that’s delayed in the stomach prevents spikes in your blood glucose and makes you feel full faster and for longer.
A downside to slower digestion is that it can affect how oral birth control is absorbed from your digestive tract. This could mean less medication is absorbed than what’s supposed to be, potentially causing birth control to be less effective. This interaction is most significant when first starting Mounjaro and shortly after any dose increases.
Mounjaro can also cause a number of digestive-related side effects, such as vomiting and diarrhea. Vomiting shortly after a dose of birth control can prevent proper absorption. Diarrhea — particularly diarrhea that continues for 2 days or longer — can also prevent full absorption.
Non-oral methods of birth control, such as the patch or ring, may be better options, as they’re not affected by Mounjaro. You can also use a barrier method, such as condoms. These alternative birth control options should be used for the first 4 weeks after starting Mounjaro and for 4 weeks anytime your dose increases.
Delayed stomach emptying can also affect the absorption of other oral medications, similar to Mounjaro’s interaction with birth control pills.
This may be concerning if you take medications that are highly sensitive to small changes in dose, like warfarin (Coumadin, Jantoven). Warfarin can cause serious side effects, like blood clots or bleeding, even when slight changes in its levels happen. Your warfarin prescriber may recommend monitoring your blood work more frequently when you start Mounjaro.
Your prescriber or pharmacist can tell you if any medications you take are sensitive to small dose changes. They can also provide you with information on the best way to manage this Mounjaro interaction.
You shouldn’t take Mounjaro with other medications that work similarly. Examples include Ozempic (semaglutide) and Victoza (liraglutide). Using Mounjaro with these medications can raise your risk of side effects, such as nausea, vomiting, and diarrhea.
Other examples of medicines you shouldn’t take with Mounjaro include:
Wegovy (semaglutide)
Rybelsus (semaglutide)
Trulicity (dulaglutide)
Saxenda (liraglutide)
Byetta (exenatide)
Bydureon BCise (exenatide)
Zepbound (tirzepatide)
Talk with your endocrinologist if you’re not achieving your desired results with Mounjaro. They can help you explore other options.
Key Mounjaro (tirzepatide) drug interactions include insulin, sulfonylureas, and glinides. Taking them together can cause your blood glucose (sugar) to drop too low. Mounjaro can also make birth control pills less effective and may affect how your body absorbs other oral medications.
You shouldn’t take Mounjaro with other medications that work similarly to it, such as Ozempic (semaglutide) or Victoza (liraglutide). Combining them raises the risk of side effects, such as nausea and diarrhea.
Contact your endocrinologist if you have any questions about potential Mounjaro drug interactions. They can adjust your medication dosages if needed and help you limit interactions.
Eli Lilly and Company. (2023). Mounjaro injection, for subcutaneous use [package insert].
MedlinePlus. (2023). Tirzepatide injection.
Rzzaki, T. S., et al. (2022). Tirzepatide: Does the evidence to date show potential for the treatment of early stage type 2 diabetes? Therapeutics and Clinical Risk Management.
U.S. Food and Drug Administration. (2017). FY2015 regulatory science research report: Narrow therapeutic index drugs.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.